Severe hepatocellular injury after hematopoietic cell transplant: Incidence, etiology and outcome

Bone Marrow Transplantation

Volumn 44, Issue 7, 2009, Pages 441-447

  Sakai, M ^a   Strasser, S I ^b   Shulman, H M ^a,c   McDonald, S J ^a   Schoch, H G ^a   McDonald, G B ^a,c  

^a USA   (United States)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B LIPID COMPLEX; BILIRUBIN;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CAUSAL ATTRIBUTION; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FATALITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS; HERPES ZOSTER; HUMAN; HYPOXEMIA; HYPOXIA; INCIDENCE; LIVER CELL DAMAGE; LIVER DISEASE; LIVER ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SINUSOIDAL OBSTRUCTION SYNDROME; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANOXIA; CELL HYPOXIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC INSUFFICIENCY; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; INCIDENCE; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70350271485     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.56     Document Type: Review

References (33)

1. Strasser SI, McDonald GB. Gastrointestinal and hepatic complications. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell Publishing: Oxford, UK, 2009, pp 1434-1455.
2. Gooley TA, Rajvanshi P, Schoch HG, McDonald GB. Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation. Hepatology 2005; 41: 345-352.
3. El-Sayed MH, El-Haddad A, Fahmy OA, Salama II, Mahmoud HK. Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation. Eur J Gastroenterol Hepatol 2004; 16: 1347-1354.
4. Kim B, Chung K, Sun H, Suh J, Min W, Kang C et al. Liver disease during the first posttransplant year in bone marrow transplantation recipients: Retrospective study. Bone Marrow Transplant 2000; 26: 193-197.
5. McDonald GB. Management of hepatic disease following hematopoietic cell transplant. Alimentary Pharmacol Ther 2006; 24: 441-452.
6. Shulman HM, McDonald GB. Hepatic complications of hematopoietic cell transplantation. In: Gershwin ME, Vierling JM, Manns M (eds). Liver Immunology: Principles and Practice. Humana Press: Totowa, NJ, 2007, pp 409-421.
7. Strasser SI, Myerson D, Spurgeon CL, Sullivan KM, Storer B, Schoch HG et al. Hepatitis C virus infection after bone marrow transplantation: a cohort study with 10 year follow-up. Hepatology 1999; 29: 1893-1899.
8. Ruutu T, Eriksson B, Remes K, Juvonen E, Volin L, Remberger M et al Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 2002; 100: 1977-1983.
9. Ho G-T, Parker A, MacKenzie JF, Morris AJ, Stanley AJ. Abnormal liver function tests following bone marrow transplantation: Aetiology and role of liver biopsy. Eur J Gastroenterol Hepatol 2004; 16: 157-162.
10. Sucak G, Yegin Z, Ozkurt Z, Aki S, Karakan T, Akyol G. The role of liver biopsy in the workup of liver dysfunction late after SCT: Is the role of iron overload underestimated? Bone Marrow Transplant 2008; 42 461-467.
11. Lau GKK, Strasser SI, McDonald GB. Hepatitis virus infections in patients with cancer. In: Wingard JR, Bowden RA (eds). Management of Infection in Oncology Patients. Martin Dunitz: London, UK, 2003, pp 321-342.
12. Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: Clinical and hemodynamic study in 142 consecutive cases. Medicine 2003; 82: 392-406.
13. Deleve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (venocclusive disease). Semin Liver Dis 2002; 22: 27-41.
14. Kaplowitz N, DeLeve LD (eds). Drug Induced Liver Disease, 2nd edn. Informa Healthcare USA, Inc.: New York, 2007.
15. Strasser SI, Shulman HM, McDonald GB. Cholestasis after hematopoietic cell transplantation. Clin Liver Dis 1999; 3: 651-668.
16. Rossi MR, Longoni DV, Rovelli AM, Uderzo C. Severe rhabdomyolysis, hyperthermia and shock after amphotericin B colloidal dispersion in an allogeneic bone marrow transplant recipient. Pediatr Infect Dis J 2000; 19: 172-173.
17. Tong J, Laport G, Lowsky R. Rhabdomyolysis after concomitant use of cyclosporine and simvastatin in a patient transplanted for multiple myeloma. Bone Marrow Transplant 2005; 36: 739-740.
18. Rajvanshi P, Shulman HM, Sievers EL, McDonald GB. Hepatic sinusoidal obstruction following Gemtuzumab ozogamicin (Mylotarg) therapy. Blood 2002; 99: 4245-4246.
19. McDonald GB, Hinds MS, Fisher LB, Schoch HG, Wolford JL, Banaji M et al. Venocclusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
20. Fischer MA, Winkelmayer WC, Rubin RH, Avorn J. The hepatotoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis 2005; 41: 301-307.
21. Honjo I, Suou T, Hirayama C. Hepatotoxicity of cyclophosphamide in man: pharmacokinetic analysis. Res Commun Chem Pathol Pharmacol 1988; 61: 149-165.
22. Gnann J. Herpes simplex and varicella zoster virus infection after hemopoietic stem cell or solid organ transplantation. In: Bowden RA, Ljungman P, Paya CV (eds). Transplant Infections. 2nd edn. Lippincott Williams and Wilkins: Philadelphia, 2003, pp 350-366.
23. Shields AF, Hackman RC, Fife KH, Corey L, Meyer JD. Adenovirus infections in patients undergoing bone marrow transplantation. N Engl J Med 1985; 312: 529-533.
24. Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A et al Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant 2007; 13: 74-81.
25. Wang WH, Wang HL. Fulminant adenovirus hepatitis following bone marrow transplantation. A case report and brief review of the literature. Arch Pathol Lab Med 2003; 127: E246-e248.
26. Strasser SI, Shulman HM, Flowers ME, Reddy R, Margolis DA, Prumbaum M et al. Chronic graft-vs-host disease of the liver: Presentation as an acute hepatitis. Hepatology 2000; 32: 1265-1271.
27. Akpek G, Boitnott JK, Lee LA, Hallick JP, Torbenson M, Jacobsohn DA et al. Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood 2002; 100: 3903-3907.
28. Sakai M, McDonald GB. Gastrointestinal and hepatic manifestations of chronic GVHD. In: Vogelsang G, Pavletic S (eds). Chronic Graft-Versus-Host Disease: Interdisciplinary Management. Cambridge University Press: New York, NY, 2009, pp 216-228.
29. Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB. Venocclusive disease of the liver after marrow transplantation: Histologic correlates of clinical signs and symptoms. Hepatology 1994; 19: 1171-1180.
30. Traber PG, Chianale J, Gumucio JJ. Physiologic significance and regulation of hepatocellular heterogeneity. Gastroenterology 1988; 95: 1130-1143.
31. McKoy JM, Angelotta C, Bennett CL, Tallman MS, Wadleigh M, Evens AM et al. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project. Leuk Res 2007; 31: 599-604.
32. McDonald GB, Frieze D. A problem-oriented approach to liver disease in oncology patients. Gut 2008; 57: 987-1003.
33. McDonald GB, Schoch H, Gooley T. Liver complications of allogeneic hematopoietic cell transplant: Declining incidence related to changes in practice (Abstract). Hepatology 2008; 48(Suppl): 318A-319A.